Prodesse Inc.
Prodesse Inc. of Waukesha, Wis., and
Invitrogen Corp. of Carlsbad, Calif., have signed a licensing agreement for diagnostic
assays that incorporate the latter company’s Lux technology, reagents used
in gene expression studies, biomarker analysis and functional genomics experiments.
The arrangement will use Prodesse’s distribution capabilities to bring the
technology to new market segments.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024